General Information of This Metabolic Reaction (MR) (ID:
MR009262) |
Formula |
|
Reactant |
Neupro |
Product |
Neupro Metabolite M5 |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Sulfotransferase 1A1 (SULT1A1)
|
DME Info
|
Sulfotransferase 1A2 (SULT1A2)
|
DME Info
|
Sulfotransferase 1A3 (SULT1A3)
|
DME Info
|
Sulfotransferase 1B1 (SULT1B1)
|
DME Info
|
Sulfotransferase 1C4 (SULT1C4)
|
DME Info
|
Sulfotransferase 1E1 (SULT1E1)
|
DME Info
|
Metabolic Type
|
Unclear
-
Unclear
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
References |
1 |
Absorption, disposition, metabolic fate, and elimination of the dopamine agonist rotigotine in man: administration by intravenous infusion or transdermal delivery
|
2 |
No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine
|
3 |
Determination of the dopamine D2 agonist N-0923 and its major metabolites in perfused rat livers by HPLC-UV-atmospheric pressure ionization mass spectrometry
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.